微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.42% | -69.57% | -76.4% | 88/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 1.78% | -62.92% | -43.85% | 83/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 3.17% | -39.73% | 168.64% | 77/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.18% | -45.12% | -14.49% | 85/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.38% | 51.65% | -71.25% | 62/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 4.8% | -45.64% | -8.75% | 72/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 5.26% | -39.12% | 144.65% | 59/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.15% | -65.04% | 136.26% | 80/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.91% | -70.74% | -89.69% | 88/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 8.83% | -68.68% | 2.2% | 70/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.64% | -57.54% | 40.49% | 62/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.15% | -55.88% | 97.75% | 62/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.11% | 2% | -88.97% | 52/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 28.19% | -50.62% | 38.53% | 20/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 20.35% | 2% | 45.98% | 23/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 13.94% | -69.81% | -75.58% | 25/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 57.09% | 174.34% | 23.62% | 17/131 | 25.69% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 46.18% | 2% | 121.91% | 12/131 | 15.16% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 20.81% | 3.79% | 3.79% | 37/131 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 20.05% | 41% | 41% | 32/131 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | 14.22% | 2% | 2% | 47/131 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |